ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 761676 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 761676; 2) Community: the network communities that were significantly associated with the response to NSC 761676; 3) Molecule: the relationships between components within communities and NSC 761676; 4) MDR: the compounds that were significantly associated with the NSC 761676.

NSC Compound Enrichment Correlation
NSC 146268 as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- 0.00181889981954878 0.3824024
NSC 646278 Pyrido[3',4':4,5]thieno[2,3-g]isoquinoline, 6-methyl- 0.00181889981954878 0.25038266
NSC 693117 Null 0.00181889981954878 0.23527948
NSC 9706 Triethylenemelamine 0.00204446620781764 0.11695236
NSC 258812 N,N-Dimethyldaunomycin hydrochloride 0.00204446620781765 0.20359697
NSC 301477 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 0.00204446620781765 0.22845454
NSC 648114 ANTINEOPLASTIC-D648114 0.00204446620781765 0.17288969
NSC 648365 Insulin-Methotrexate conjugate 0.00204446620781765 0.254602
NSC 650931 2'-BROMO-4'-EPI-DAUNDRUBICIN 0.00204446620781765 0.27566343
NSC 663337 Null 0.00204446620781765 0.31388006
Total:84  Current:6    [First] [Prev] [Next] [Last]